A carregar...
Levocarnitine for valproate-induced hyperammonemia in the psychiatric setting: A case series and literature review
INTRODUCTION: Hyperammonemia is a potential adverse effect of valproic acid (VPA) therapy, which is often asymptomatic but can lead to severe, life-threatening encephalopathy. Carnitine deficiency due to VPA is the proposed mechanism for hyperammonemia and the development of VPA-induced hyperammonem...
Na minha lista:
| Publicado no: | Ment Health Clin |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
College of Psychiatric & Neurologic Pharmacists
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6007637/ https://ncbi.nlm.nih.gov/pubmed/29955560 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9740/mhc.2018.05.148 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|